Pricing Log in Create free account

Korsana Biosciences, Inc. (KRSA) vs Ocular Therapeutix, Inc. (OCUL)

Korsana Biosciences, Inc. and Ocular Therapeutix, Inc. are both Biotechnology companies. Korsana Biosciences, Inc. and Ocular Therapeutix, Inc. are of similar size ($1.4B and $1.4B). Ocular Therapeutix, Inc. grew revenue faster over the last twelve months: −8.14% against −28.8%. Korsana Biosciences, Inc. has the higher net margin (0.00% vs −579.1%) and the lower return on invested capital (−115.4% vs 0.00%). Across the 18 metrics below, Korsana Biosciences, Inc. leads on 9 and Ocular Therapeutix, Inc. on 9.

Valuation

Metric KRSA OCUL Biotechnology median
P/E n/m n/m 10.60
P/S 9.01 28.61 9.40
P/B 3.67 2.86 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 8.34 18.51 9.02
Earnings yield (38.12%) (21.45%) (32.88%)
Free cash flow yield (24.20%) (17.13%) (23.13%)

Profitability

Metric KRSA OCUL Biotechnology median
Gross margin 100.00% 87.11% 68.51%
Operating margin 0.00% (603.04%) 0.00%
Net margin 0.00% (579.10%) 0.00%
Free cash flow margin 0.00% (490.07%) 0.00%
Return on equity (98.22%) (72.99%) (51.96%)
Return on assets (82.29%) (53.70%) (46.06%)
Return on invested capital (115.40%) 0.00% 0.00%

Growth

Metric KRSA OCUL Biotechnology median
Revenue growth (TTM) (28.83%) (8.14%) 6.76%
EPS growth (last fiscal year) 8.26% (16.39%) 29.88%
Revenue growth, 5-year CAGR (14.38%) 24.45% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KRSA OCUL Biotechnology median
Debt to equity 0.00 0.14 0.00
Current ratio 0.82 13.11 4.97
Net debt to EBITDA 0.65 2.51 1.01

Dividend

Metric KRSA OCUL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KRSA OCUL Biotechnology median
Market cap 1.39b 1.41b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack